Dopamine-Serotonin System Interactions (Sikiri et al., 2010) Extended research confirmed BPC-157 affects dopamine, serotonin, and their metabolites across multiple brain regions including the striatum, nucleus accumbens, and prefrontal cortex
Recommended reconstitution by protocol phase This phased approach uses different vial sizes at different stages, matching the vial to the dose rather than forcing one size to work across all phases
While many peptides show promise in regenerative, longevity, and personalized medicine, most remain unapproved by regulatory bodies due to a lack of human trials
Human clinical applications remain unestablished
A consult can also sort whether a procedure, a peptide, or both makes sense for you